$NVRO
NEVRO CORP

2022 Q4 Form 10-Q Financial Statement

#000095017022021299 Filed on November 02, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $113.8M $100.5M $93.21M
YoY Change 10.79% 7.79% -14.07%
Cost Of Revenue $38.61M $31.16M $28.58M
YoY Change 14.8% 9.06% -11.81%
Gross Profit $75.24M $69.30M $64.63M
YoY Change 8.83% 7.23% -15.05%
Gross Profit Margin 66.09% 68.98% 69.34%
Selling, General & Admin $80.65M $78.19M $79.52M
YoY Change -2.41% -1.67% 16.09%
% of Gross Profit 107.19% 112.83% 123.04%
Research & Development $13.95M $14.03M $11.55M
YoY Change 9.74% 21.44% 4.08%
% of Gross Profit 18.54% 20.24% 17.88%
Depreciation & Amortization $1.522M $1.602M $1.220M
YoY Change 7.79% 31.31% 3.92%
% of Gross Profit 2.02% 2.31% 1.89%
Operating Expenses $94.60M -$12.78M $91.07M
YoY Change -0.79% -114.03% 14.41%
Operating Profit -$19.36M $82.08M -$26.44M
YoY Change -26.16% -410.4% 645.11%
Interest Expense $855.0K $1.608M -$3.589M
YoY Change -117.46% -144.8% -42.11%
% of Operating Profit 1.96%
Other Income/Expense, Net -$333.0K $391.0K $30.00K
YoY Change -136.96% 1203.33%
Pretax Income -$18.84M $81.99M -$50.00M
YoY Change -37.65% -263.98% 410.23%
Income Tax $356.0K $485.0K $72.00K
% Of Pretax Income 0.59%
Net Earnings -$19.19M $81.51M -$50.08M
YoY Change -36.31% -262.77% 401.5%
Net Earnings / Revenue -16.86% 81.13% -53.73%
Basic Earnings Per Share $2.30 -$1.44
Diluted Earnings Per Share -$0.54 $2.22 -$1.436M
COMMON SHARES
Basic Shares Outstanding 35.43M 35.39M 34.88M
Diluted Shares Outstanding 37.34M 34.88M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $374.4M $386.9M $376.6M
YoY Change 3.41% 2.74% -34.27%
Cash & Equivalents $120.4M $130.8M $81.49M
Short-Term Investments $254.0M $256.1M $295.7M
Other Short-Term Assets $9.984M $11.08M $7.036M
YoY Change 92.56% 57.48% 8.25%
Inventory $99.64M $98.53M $91.80M
Prepaid Expenses
Receivables $78.93M $69.57M $63.46M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $562.9M $566.1M $538.9M
YoY Change 5.97% 5.05% -27.41%
LONG-TERM ASSETS
Property, Plant & Equipment $22.27M $21.17M $20.30M
YoY Change 7.78% 4.29% 65.96%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.164M $3.163M $5.062M
YoY Change -29.58% -37.51% 3.31%
Total Long-Term Assets $39.47M $39.44M $43.56M
YoY Change -8.93% -9.46% 20.67%
TOTAL ASSETS
Total Short-Term Assets $562.9M $566.1M $538.9M
Total Long-Term Assets $39.47M $39.44M $43.56M
Total Assets $602.4M $605.5M $582.4M
YoY Change 4.85% 3.96% -25.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.85M $31.84M $32.76M
YoY Change -16.09% -2.8% 33.69%
Accrued Expenses $47.17M $43.39M $37.63M
YoY Change 3.63% 15.29% -15.38%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $79.21M $80.30M $74.85M
YoY Change -3.64% 7.28% -68.74%
LONG-TERM LIABILITIES
Long-Term Debt $186.9M $186.6M $148.8M
YoY Change 23.5% 25.37% 6.67%
Other Long-Term Liabilities $2.157M $2.096M $39.57M
YoY Change -90.2% -94.7% 100.88%
Total Long-Term Liabilities $189.0M $188.7M $188.4M
YoY Change 9.06% 0.15% 18.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $79.21M $80.30M $74.85M
Total Long-Term Liabilities $189.0M $188.7M $188.4M
Total Liabilities $278.5M $280.6M $263.2M
YoY Change 2.81% 6.59% -33.98%
SHAREHOLDERS EQUITY
Retained Earnings -$607.2M -$588.0M -$594.1M
YoY Change -2.72% -1.03% 22.32%
Common Stock $934.2M $918.0M
YoY Change 0.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $323.9M $324.9M $319.2M
YoY Change
Total Liabilities & Shareholders Equity $602.4M $605.5M $582.4M
YoY Change 4.85% 3.96% -25.18%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$19.19M $81.51M -$50.08M
YoY Change -36.31% -262.77% 401.5%
Depreciation, Depletion And Amortization $1.522M $1.602M $1.220M
YoY Change 7.79% 31.31% 3.92%
Cash From Operating Activities -$13.42M $79.35M -$15.36M
YoY Change -11.45% -616.53% -235.59%
INVESTING ACTIVITIES
Capital Expenditures $2.387M -$2.113M -$3.675M
YoY Change -237.98% -42.5% 162.5%
Acquisitions
YoY Change
Other Investing Activities $2.845M -$54.39M -$44.51M
YoY Change -108.75% 22.2% -73.62%
Cash From Investing Activities $458.0K -$56.50M -$48.19M
YoY Change -101.34% 17.26% -71.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.374M 37.00K -1.325M
YoY Change -58.06% -102.79% -274.34%
NET CHANGE
Cash From Operating Activities -13.42M 79.35M -15.36M
Cash From Investing Activities 458.0K -56.50M -48.19M
Cash From Financing Activities 1.374M 37.00K -1.325M
Net Change In Cash -11.59M 22.88M -64.87M
YoY Change -74.87% -135.27% -58.95%
FREE CASH FLOW
Cash From Operating Activities -$13.42M $79.35M -$15.36M
Capital Expenditures $2.387M -$2.113M -$3.675M
Free Cash Flow -$15.81M $81.46M -$11.69M
YoY Change 17.73% -797.04% -191.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-310000
dei Security Exchange Name
SecurityExchangeName
NYSE
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3470000
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-515000
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
35430089
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
130839000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34710000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
256057000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
327317000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1222000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1385000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
69572000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
70475000
CY2022Q3 us-gaap Inventory Net
InventoryNet
98525000
CY2021Q4 us-gaap Inventory Net
InventoryNet
93517000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11080000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5185000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
566073000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
531204000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21173000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20664000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14497000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17577000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3163000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36715
dei Entity Registrant Name
EntityRegistrantName
Nevro Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
56-2568057
dei Entity Address Address Line1
EntityAddressAddressLine1
1800 Bridge Parkway
dei Entity Address City Or Town
EntityAddressCityOrTown
Redwood City
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94065
dei City Area Code
CityAreaCode
650
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
NVRO
dei Local Phone Number
LocalPhoneNumber
251-0005
CY2022Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Central Index Key
EntityCentralIndexKey
0001444380
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4493000
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
606000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
606000
CY2022Q3 us-gaap Assets
Assets
605512000
CY2021Q4 us-gaap Assets
Assets
574544000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
31839000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
31999000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
43388000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
45517000
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5071000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4687000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
80298000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
82203000
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
186559000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
151310000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11624000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15402000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2096000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
22013000
CY2022Q3 us-gaap Liabilities
Liabilities
280577000
CY2021Q4 us-gaap Liabilities
Liabilities
270928000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
290000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
290000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36107515
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35709570
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35424599
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35026654
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
35000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
35000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
917946000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
928138000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5041000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-364000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-588005000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-624193000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
324935000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
303616000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
605512000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
574544000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
100466000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
93205000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
292521000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
284145000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
31164000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
28575000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
91393000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
87235000
CY2022Q3 us-gaap Gross Profit
GrossProfit
69302000
CY2021Q3 us-gaap Gross Profit
GrossProfit
64630000
us-gaap Gross Profit
GrossProfit
201128000
us-gaap Gross Profit
GrossProfit
196910000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14030000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11553000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39118000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
34956000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
78190000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
79521000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
241488000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
226673000
CY2022Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
-105000000
CY2021Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
20000000
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
-105000000
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
20000000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
-12780000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
111074000
us-gaap Operating Expenses
OperatingExpenses
175606000
us-gaap Operating Expenses
OperatingExpenses
281629000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
82082000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-46444000
us-gaap Operating Income Loss
OperatingIncomeLoss
25522000
us-gaap Operating Income Loss
OperatingIncomeLoss
-84719000
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1128000
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
99000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1553000
us-gaap Investment Income Interest
InvestmentIncomeInterest
559000
CY2022Q3 us-gaap Interest Expense
InterestExpense
1608000
CY2021Q3 us-gaap Interest Expense
InterestExpense
3688000
us-gaap Interest Expense
InterestExpense
4819000
us-gaap Interest Expense
InterestExpense
15939000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
391000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
30000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
844000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
81993000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-50003000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23100000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-100614000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
485000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
72000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
907000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
612000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
81508000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-50075000
us-gaap Net Income Loss
NetIncomeLoss
22193000
us-gaap Net Income Loss
NetIncomeLoss
-101226000
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1690000
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-401000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-3293000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-651000
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-102000
CY2021Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-8000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1384000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-127000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1792000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-409000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4677000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-778000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
79716000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-50484000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
17516000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-102004000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.30
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.91
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.22
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.91
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35402086
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34878443
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35265193
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34774423
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37338945
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34878443
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35501609
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34774423
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
303616000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
545000
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
7298000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13406000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-34325000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1213000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
240386000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
230000
CY2022Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
759000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3414000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13376000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-24990000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1672000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
229985000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
366000
CY2022Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
329000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15197000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
81508000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1792000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
324935000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
388460000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1331000
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2801000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9235000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-29561000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-459000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
366205000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
305000
CY2021Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2314000
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
4648000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11032000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-21590000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
90000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
358376000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
51000
CY2021Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1375000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12634000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-50075000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-409000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
319202000
us-gaap Profit Loss
ProfitLoss
22193000
us-gaap Profit Loss
ProfitLoss
-101226000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4658000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3470000
nvro Amortization Of Operating Lease Asset
AmortizationOfOperatingLeaseAsset
3080000
nvro Amortization Of Operating Lease Asset
AmortizationOfOperatingLeaseAsset
2806000
us-gaap Share Based Compensation
ShareBasedCompensation
41992000
us-gaap Share Based Compensation
ShareBasedCompensation
32908000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-888000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1008000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
280000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-1222000
us-gaap Inventory Write Down
InventoryWriteDown
3638000
us-gaap Inventory Write Down
InventoryWriteDown
3707000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
905000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
10759000
nvro Unrealized Gains And Losses On Foreign Currency Translation
UnrealizedGainsAndLossesOnForeignCurrencyTranslation
1737000
nvro Unrealized Gains And Losses On Foreign Currency Translation
UnrealizedGainsAndLossesOnForeignCurrencyTranslation
-2753000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
964000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-14983000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7207000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
23236000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5949000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2878000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1325000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
416000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
17896000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1000000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4718000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-23694000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
16684000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
38098000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26722000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
188063000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
354614000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
257050000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
601171000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5155000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10610000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
63832000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
235947000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
172500000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8386000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6491000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
4555000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
6334000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3831000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-172657000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1970000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-280000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
96129000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
36288000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
35316000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
45203000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
131445000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
81491000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
533000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
482000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y2M12D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.070
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.070
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Estimates are based on historical experience, where applicable, and other assumptions believed to be reasonable by the management. Actual results may differ from those estimates under different assumptions or conditions.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The COVID-19 pandemic has negatively impacted, and may continue to negatively impact the Company’s operations and revenues and overall financial condition. Due to the COVID-19 pandemic, there has been uncertainty and disruption in the global economy and financial markets which could impact the Company’s estimates and assumptions. Changes in the Company’s assessment about the length and severity of the pandemic, as well as other factors, could result in actual results differing from estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
1026000
CY2021Q3 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-745000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
2249000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-2861000
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-585000
CY2021Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
787000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-1296000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
2385000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
100466000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
93205000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
292521000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
284145000
CY2022Q3 nvro Bad Debt Expense1
BadDebtExpense1
7000
nvro Bad Debt Expense1
BadDebtExpense1
200000
CY2021Q3 nvro Bad Debt Expense1
BadDebtExpense1
14000
nvro Bad Debt Expense1
BadDebtExpense1
100000
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M25D
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1478000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6019000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6201000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2849000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
405000
CY2022Q3 nvro Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
1978000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
18930000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2236000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
16694000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1342000
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1333000
us-gaap Operating Lease Cost
OperatingLeaseCost
4027000
us-gaap Operating Lease Cost
OperatingLeaseCost
3901000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14497000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17577000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5070000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4588000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11624000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15402000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
16694000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
19990000
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1478000
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1373000
us-gaap Operating Lease Payments
OperatingLeasePayments
4242000
us-gaap Operating Lease Payments
OperatingLeasePayments
3880000
CY2022Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
109600000
CY2021Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
9600000
CY2022Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
16600000
CY2021Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
8600000
CY2022Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
257807000
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
11000
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1761000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
256057000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
332692000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
4000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
371000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
332325000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
43319000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
27308000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22655000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21173000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20664000
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1602000
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1220000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4658000
CY2022Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
228000000
CY2022Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
226300000
CY2022Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
29807000
CY2022Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
29757000
CY2022Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
257807000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
256057000
CY2021Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
664000
CY2020Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
699000
CY2022Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
822000
CY2021Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
622000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
2325000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1899000
CY2022Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
47869000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
50160000
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
50656000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
43357000
CY2022Q3 us-gaap Inventory Net
InventoryNet
98525000
CY2021Q4 us-gaap Inventory Net
InventoryNet
93517000
CY2022Q3 nvro Inventory Write Down Cash And Non Cash
InventoryWriteDownCashAndNonCash
1400000
CY2021Q3 nvro Inventory Write Down Cash And Non Cash
InventoryWriteDownCashAndNonCash
700000
nvro Inventory Write Down Cash And Non Cash
InventoryWriteDownCashAndNonCash
3600000
nvro Inventory Write Down Cash And Non Cash
InventoryWriteDownCashAndNonCash
3700000
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
48481000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
33396000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
30957000
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1038000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
6547000
CY2022Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1334000
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1074000
CY2022Q3 nvro Accrued Clinical And Research Expenses Current
AccruedClinicalAndResearchExpensesCurrent
195000
CY2021Q4 nvro Accrued Clinical And Research Expenses Current
AccruedClinicalAndResearchExpensesCurrent
305000
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
2609000
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1305000
CY2022Q3 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
751000
CY2021Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
664000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4065000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4665000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
43388000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
45517000
CY2021Q2 nvro Additional Operating Lease Right Of Use Asset
AdditionalOperatingLeaseRightOfUseAsset
2900000
CY2021Q2 nvro Additional Operating Lease Liability
AdditionalOperatingLeaseLiability
2900000
us-gaap Standard Product Warranty Description
StandardProductWarrantyDescription
limited one- to five-year warranty
CY2022Q2 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
636000
CY2021Q2 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
822000
CY2022Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
707000
CY2021Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
900000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
2238000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
2054000
CY2022Q3 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
751000
CY2021Q3 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
544000
CY2022Q3 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
751000
CY2021Q3 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
544000
CY2021Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
20000000.0
CY2021Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
20000000.0
CY2022Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
20000000.0
CY2021Q4 nvro Other Loss Contingency Accrual At Carrying Value
OtherLossContingencyAccrualAtCarryingValue
0
CY2022Q3 nvro Other Loss Contingency Accrual At Carrying Value
OtherLossContingencyAccrualAtCarryingValue
0
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
81508000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-50075000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
22193000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-101226000
CY2022Q3 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
1305000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
82813000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-50075000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
22193000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-101226000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35402086
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34878443
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35265193
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34774423
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
129718
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
236416
CY2022Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
1807141
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37338945
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34878443
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35501609
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34774423
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.30
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.91
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.22
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.91
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
942445
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1807141
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2175523
CY2022Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
400000
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
3300000
CY2021Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
200000
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
2800000
nvro Employee Stock Purchase Plan Offering Period
EmployeeStockPurchasePlanOfferingPeriod
P6M

Files In Submission

Name View Source Status
0000950170-22-021299-index-headers.html Edgar Link pending
0000950170-22-021299-index.html Edgar Link pending
0000950170-22-021299.txt Edgar Link pending
0000950170-22-021299-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nvro-20220930.htm Edgar Link pending
nvro-20220930.xsd Edgar Link pending
nvro-ex31_1.htm Edgar Link pending
nvro-ex31_2.htm Edgar Link pending
nvro-ex32_1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
nvro-20220930_cal.xml Edgar Link unprocessable
nvro-20220930_pre.xml Edgar Link unprocessable
nvro-20220930_lab.xml Edgar Link unprocessable
nvro-20220930_def.xml Edgar Link unprocessable
nvro-20220930_htm.xml Edgar Link completed
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending